Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin vs Levofloxacin in Chronic Bacterial Prostatitis
NCT03201796Phase 2Completed
- Sponsor
- Angelini Pharma
- Start
- Feb 2016
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of prulifloxacin in chronic bacterial prostatitis (CBP), sponsored by Angelini Pharma. Started Feb 2016; status: completed.
02
Drugs
prulifloxacin
03
Conditions
chronic bacterial prostatitis (CBP)
Beyond the preview
Go deeper on NCT03201796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03201796.